{"id":"W1861098450","doi":"10.1111/nep.12362","title":"The rationale and design of the <scp>B</scp>eta‐blocker to <scp>LO</scp>wer <scp>CA</scp>rdiovascular <scp>D</scp>ialysis <scp>E</scp>vents (<scp>BLOCADE</scp>) <scp>F</scp>easibility <scp>S</scp>tudy","year":2014,"lang":"en","type":"article","venue":"Nephrology","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"Health Research Council of New Zealand; National Health and Medical Research Council; Pfizer Australia","keywords":"Carvedilol; Medicine; Placebo; Dialysis; Clinical endpoint; Randomized controlled trial; Beta blocker; Clinical trial; Incidence (geometry); Internal medicine; Heart failure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08014461,0.002095338,0.002405693,0.001419127,0.002877207,0.003497092,0.004284102,0.007281556,0.01160403],"category_scores_gemma":[0.04586893,0.001800683,0.002146349,0.001163955,0.008184174,0.002514822,0.003118828,0.009824567,0.00490805],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002969152,"about_ca_system_score_gemma":0.01265938,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001065366,"about_ca_topic_score_gemma":0.001398257,"domain_scores_codex":[0.952241,0.03700454,0.00254773,0.003311496,0.003706811,0.001188405],"domain_scores_gemma":[0.9644923,0.01754273,0.003292262,0.004285683,0.006408081,0.003978951],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1489277,0.02550314,0.008830246,0.01443853,0.001205252,0.001386571,0.006938936,0.00656374,0.02914436,0.497532,0.0410094,0.2185201],"study_design_scores_gemma":[0.202417,0.1132535,0.01240337,0.006928612,0.003490651,0.002092732,0.001879946,0.02221415,0.02147217,0.2100794,0.4027462,0.001022243],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.04098727,0.00904468,0.3979226,0.03128048,0.009700703,0.4805531,0.002917379,0.0005839042,0.02700991],"genre_scores_gemma":[0.09440526,0.002631191,0.3300187,0.01658498,0.001878135,0.5474626,0.0003786349,0.00009501797,0.006545554],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.08014461,"threshold_uncertainty_score":0.4238502,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01566932446801575,"score_gpt":0.2426317539402194,"score_spread":0.2269624294722037,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}